HEALTHCARE

15 Oct 2018

Results from Pradaxa® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke Congress

  • Data from key trials will aid in increasing scientific understanding of ESUS and CVT
  • RESPECT-ESUS is first randomised trial to investigate clinical profile of Pradaxa® vs ASA

(...

Continue Reading

15 Oct 2018

Julphar Announces Entry into Oncology Market

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced its entry into the oncology market through a license and supply agreement with Russia’s leading biotechnology company, BIOCAD.

Julphar"...

Continue Reading

11 Oct 2018

Baheya honours breast cancer fighters

Celebrating the National Breast Cancer Awareness Month (NBCAM), Baheya Foundation For Treatment Of Breast Cancer welcomed October, by organising an event to award breast cancer fighters, and raise people’s awareness of the symptoms its treatment.

The"...

Continue Reading

11 Oct 2018

Dubai’s Jehad Medical Clinic Bags JCI for the Third Time

Jehad International Medical Clinic (JIMC), a specialised medical service provider in Dubai, has achieved accreditation by the Joint Commission International (JCI) for the third time. This accreditation is for the medical facility’s commitment to"...

Continue Reading

11 Oct 2018

Plant Oil-Extracted Active Ingredient, Blue Oléoactif®, Wins Silver For Hallstar at in-cosmetics Latin America

Hallstar, a specialty chemical company headquartered in Chicago, has been awarded the 2018 ITEHPEC Innovation Silver Prize for its anti-blue light, anti-pollution, eco-designed active, BLUE Oléoactif®.

The"...

Continue Reading

11 Oct 2018

Breast Reconstruction Awareness: A Ray of Hope Post Mastectomy Surgery

When a 40-year-old, Maryam, an Arab national was diagnosed with advanced stage breast cancer, she found herself in the hardest battle of her life. Maryam discovered her condition when she visited her doctor for a regular check-up. What came next, left her devastated. She was diagnosed with"...

Continue Reading

10 Oct 2018

Janssen Submits European Marketing Authorisation Application for Esketamine Nasal Spray for Treatment-Resistant Depression

FOR MEDICAL AND TRADE MEDIA ONLY

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA)"...

Continue Reading

10 Oct 2018

Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing

MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, is now arriving with genomics researchers. Scientists will use it to run the MinION DNA/RNA sequencer, opening up high-throughput, real-time nanopore sequencing to more users in more locations.

MinIT"...

Continue Reading

10 Oct 2018

New analysis estimates the positive impact of empagliflozin on prolonging life expectancy in adults with type 2 diabetes and established cardiovascular disease

  • Survival estimates from the EMPA-REG OUTCOME® trial data demonstrate potential long-term benefit of empagliflozin (marketed as Jardiance®) on life expectancy of adults with type 2 diabetes and cardiovascular disease1

Today,"...

Continue Reading

10 Oct 2018

New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018

Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12-month data from SUNBEAM™ pivotal trial

In separate post hoc analysis of pooled data from phase 3 RADIANCE™ Part B"...

Continue Reading
Found articles: - Pages  
Contact US | Powered by CNPHUB.com - All Rights Reserved